Granahan Investment Management LLC reduced its stake in shares of Nova Ltd. (NASDAQ:NVMI – Free Report) by 42.1% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 7,985 shares of the semiconductor company’s stock after selling 5,798 shares during the period. Granahan Investment Management LLC’s holdings in Nova were worth $3,468,000 at the end of the most recent quarter.
A number of other institutional investors have also recently made changes to their positions in NVMI. Harel Insurance Investments & Financial Services Ltd. increased its stake in shares of Nova by 47.5% in the first quarter. Harel Insurance Investments & Financial Services Ltd. now owns 2,166,073 shares of the semiconductor company’s stock valued at $940,683,000 after buying an additional 697,210 shares during the period. Invesco Ltd. lifted its stake in shares of Nova by 185.4% in the third quarter. Invesco Ltd. now owns 607,344 shares of the semiconductor company’s stock worth $194,144,000 after acquiring an additional 394,544 shares during the period. Phoenix Financial Ltd. lifted its stake in shares of Nova by 286.3% in the fourth quarter. Phoenix Financial Ltd. now owns 508,641 shares of the semiconductor company’s stock worth $167,115,000 after acquiring an additional 376,974 shares during the period. Norges Bank bought a new stake in Nova in the fourth quarter valued at approximately $109,568,000. Finally, Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in Nova during the 4th quarter valued at approximately $56,158,000. Institutional investors own 82.99% of the company’s stock.
Nova Stock Performance
Shares of NVMI stock opened at $437.98 on Friday. The company has a market cap of $13.92 billion, a P/E ratio of 54.61, a PEG ratio of 3.17 and a beta of 1.74. The stock has a 50 day simple moving average of $501.31 and a two-hundred day simple moving average of $476.11. Nova Ltd. has a fifty-two week low of $232.73 and a fifty-two week high of $615.99.
Wall Street Analyst Weigh In
Several research firms have issued reports on NVMI. Morgan Stanley raised their price target on shares of Nova from $494.00 to $540.00 and gave the stock an “equal weight” rating in a report on Monday, July 6th. Citigroup upped their price objective on shares of Nova from $520.00 to $595.00 and gave the company a “buy” rating in a research note on Friday, May 15th. Needham & Company LLC increased their price objective on shares of Nova from $500.00 to $640.00 and gave the stock a “buy” rating in a research report on Thursday, May 14th. Evercore reissued an “outperform” rating and set a $600.00 target price on shares of Nova in a research note on Friday, May 15th. Finally, Jefferies Financial Group boosted their target price on shares of Nova from $520.00 to $640.00 and gave the company a “buy” rating in a report on Thursday, May 14th. Eight analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $556.67.
View Our Latest Stock Analysis on Nova
Insider Activity at Nova
In related news, Director Eitan Oppenhaim sold 1,504 shares of the stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $519.48, for a total transaction of $781,297.92. Following the transaction, the director directly owned 6,668 shares of the company’s stock, valued at $3,463,892.64. This represents a 18.40% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Gabriel Waisman sold 2,966 shares of the firm’s stock in a transaction on Thursday, July 2nd. The stock was sold at an average price of $501.30, for a total transaction of $1,486,855.80. Following the completion of the sale, the chief executive officer owned 28,714 shares of the company’s stock, valued at $14,394,328.20. The trade was a 9.36% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 7,798 shares of company stock worth $4,125,266 over the last quarter. 1.00% of the stock is currently owned by insiders.
Nova Company Profile
Nova Measuring Instruments Ltd (NASDAQ: NVMI) develops and supplies advanced metrology and process control systems for the semiconductor manufacturing industry. The company’s core product line includes spectroscopic ellipsometry and scatterometry tools designed to measure film thickness, critical dimensions, overlay alignment and other key parameters that drive yield and performance in integrated circuit fabrication.
Founded in 1993 and headquartered in Rehovot, Israel, Nova Measuring Instruments has established itself as a critical partner to leading semiconductor foundries and device manufacturers.
Featured Stories
- Five stocks we like better than Nova
- Telecom Earnings Reveal a Sector That Finally Looks Healthier
- Defense Earnings Show Readiness Now and Modernization Ahead
- Why Palantir Investors Aren’t Panicking While the Rest of AI Sells Off
- MarketBeat Week in Review – 07/20- 07/24
Want to see what other hedge funds are holding NVMI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nova Ltd. (NASDAQ:NVMI – Free Report).
Receive News & Ratings for Nova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nova and related companies with MarketBeat.com's FREE daily email newsletter.
